TSCAN THERAPEUTICS INC (TCRX) Stock Income Statement
USA - NASDAQ:TCRX - US89854M1018 - Common Stock
1.09 USD
-0.07 (-6.03%)
1.14 USD
+0.05 (+4.59%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.96M | 2.82M | 21.05M | 13.54M | 10.14M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 151.20M | 137.64M | 114.51M | 80.17M | 58.78M | |||
| Research and Development | 117.02M | 107.35M | 88.15M | 59.82M | 44.95M | |||
| Selling, General, and Administrative Expenses | 32.81M | 30.29M | 26.35M | 20.35M | 13.83M | |||
| Operating Income | -144.24M | -134.82M | -93.46M | -66.64M | -48.64M | |||
| Interest Income/Expense | 8.55M | 8.41M | 4.24M | 420.00K | 20.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | -1.09M | null | null | null | |||
| Income Before Taxes | -136.78M | -127.50M | -89.22M | -66.22M | -48.63M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -136.78M | -127.50M | -89.22M | -66.22M | -48.63M | |||
| EBITDA | -141.12M | -130.71M | -88.10M | -61.50M | -45.31M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.0961 | -1.1385 | -1.36 | -2.75 | -2.06 | |||
| Non GAAP EPS | -1.09 | -1.1500000000000001 | -1.8900000000000001 | -2.75 | null | |||
| Statistics | ||||||||
| Profit Margin | -1964.88% | -4527.66% | -423.86% | -489.07% | -479.59% | |||
| Operating Profit Margin | -2072.07% | -4787.68% | -444.00% | -492.17% | -479.68% | |||
All data in USD